GerVetUSA will be exhibiting at the FETCH DVM 360 Conference August 23-26! Come visit us at the Kansas City Convention Center at Booth #309. We can’t wait to meet you! #Veterinarians #TradeShows #Surgeons #Pets #FetchDVM360 #GerVetUSA #KansasCity #2019 About GerVetUSA Inc GerVetUSA manufactures and sells high-quality German forged surgical instruments, which have been utilized with… Read more »
Posts Categorized: Healthcare
ISSCA Offers Stem Cells Certification at London’s Chandos House, a Royal Society of Medicine Partner
The International Society for Stem Cells Applications (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced a new stem cells certification workshop in London. The two-day workshop, held DATES, will take place at London’s Chandos House. Chandos House is a… Read more »
Dr. Rajesh Dharampuriya announces support for the Infant Brain Center to improve infant brain health
Today, the Dharampuriya Foundation, led by Dr. Rajesh Dharampuriya, announced its commitment to support the Infant Brain Center at Massachusetts General Hospital (MGH), which is committed to helping to provide exceptional medical care to infants born with, or are at-risk for, neurological impairment. Specifically, the foundation is supporting research, professional services, and patient safety into… Read more »
AVMA 2019 – Booth 1058- Walter E.Washington Convention Center (Source: GerVetUSA)
GerVetUSA is currently exhibiting at the Walter E. Washington Convention Center AVMA 2019! Couldn’t make it in today? No worries! We will be here AUGUST 2nd-5th. This is an experience you don’t want to miss. Great people, great prices & most importantly great products! Come on down, stop by Booth 1058 for more details. We… Read more »
Antonin Bukovsky announces the publication of his paper "Former Effective Immunotherapy without Adverse Events of Inoperable Epithelial Ovarian Cancers and a Prospect for the Immune Prophylaxis"
Research has shown that immune-related adverse occurrences ranged from mild to lethal. It was seen that these were found to accompany immunotherapy with checkpoint inhibitors, however, the underlying causes were still unknown. Review of 22 clinical trials (1265 cases) found that the overall incidence of adverse events was 72% and it resulted in the death… Read more »
